Transseptal Solutions, a firm based in Israel, has been given clearance to introduce its flagship TSP Crosser Transseptal Access System in the U.S. The device is used to provide a path and to deliver catheters into the left atrium of the heart.

Most minimally invasive cardiology procedures have been performed on the right side of the heart, but now mitral valve repairs, LAA closures, and ablation therapies are being performed on the left side more frequently. The TSP Crosser helps to get to the site of treatment by puncturing the fossa ovalis by first stabilizing a special ring against it and then pushing a needle through. Once inside the left atrium, a sheath is advanced through the opening through which catheters can be advanced.

The tip of the device is flexible up to 180 degrees in any direction, allowing for access to most parts of the left atrium. The ring at the working tip of the device is radiopaque, allowing the physician to constantly see where the device is under fluoroscopy and helping to stabilize it and prepare it for a correct puncture.

“Transseptal catheterization is a critical step for structural heart and electrophysiology LA interventions,” in a statement said Elad Sapir, Transseptal Solutions CEO. “The availability of advanced tools and techniques is essential to perform accurate transseptal puncture as part of challenging LA interventions.

Here’s a short video explaining the TSP Crosser and how it’s used to access the left atrium:

Product page: TSP Crosser…

Via: Transseptal Solutions…

Source link